FDA.reportPublic FDA data

brimonidine tartrate 1.5 MG/ML Ophthalmic Solution

RxCUI
861208
RxNorm name
brimonidine tartrate 1.5 MG/ML Ophthalmic Solution
Display name
brimonidine tartrate 1.5 MG/ML Ophthalmic Solution
Full name
brimonidine tartrate 1.5 MG/ML Ophthalmic Solution
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Brimonidine TartrateBRIMONIDINE TARTRATESandoz Incb1e7ebd4-d0d2-40a5-aa11-5f68bc5972bd2025-11-24Warnings, Adverse reactionsExact identifier
rxcui: 861208
Brimonidine TartrateBRIMONIDINE TARTRATEApotex Corp.64b21e68-610c-5194-ccb2-9d9f6ff8cda92025-10-08Warnings, Adverse reactionsExact identifier
rxcui: 861208
Brimonidine tartrateBRIMONIDINE TARTRATEPacific Pharma, Inc.5c4aea88-95ca-4da8-a3da-02f10c8b66232025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 861208
ALPHAGAN PBRIMONIDINE TARTRATEAllergan, Inc.264c4494-c225-486f-888a-caaf36be46b32025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 861208
Brimonidine Tartrate ophthalmic solution, 0.15%BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%Alembic Pharmaceuticals Limitede1ea003e-3dd9-41c7-9119-d1f209b9820b2023-07-06Warnings, Adverse reactionsExact identifier
rxcui: 861208
Brimonidine Tartrate ophthalmic solution, 0.15%BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%Alembic Pharmaceuticals Inc.a52b2033-0333-4630-9b1f-e22918b0962c2023-04-04Warnings, Adverse reactionsExact identifier
rxcui: 861208

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 8 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
264c4494-c225-486f-888a-caaf36be46b3brimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]324These highlights do not include all the information needed to use ALPHAGAN P safely and effectively. See full prescribing information for ALPHAGAN P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% , for topical ophthalmic use Initial U.S. Approval: 199620250918
b1e7ebd4-d0d2-40a5-aa11-5f68bc5972bdbrimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]311These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%, for topical ophthalmic use Initial U.S. Approval: 199620251124
5c4aea88-95ca-4da8-a3da-02f10c8b6623brimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]311These highlights do not include all the information needed to use Brimonidine tartrate ophthalmic solution 0.1% and 0.15% safely and effectively. See full prescribing information for brimonidine tartrate ophthalmic solution 0.1% and 0.15%. Brimonidine tartrate ophthalmic solution 0.1% and 0.15% Initial U.S. Approval: 199620250918
64b21e68-610c-5194-ccb2-9d9f6ff8cda9brimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]37These highlights do not include all the information needed to use Brimonidine Tartrate Ophthalmic Solution safely and effectively. See full prescribing information for Brimonidine Tartrate Ophthalmic Solution. Brimonidine Tartrate Ophthalmic Solution, 0.15% for topical ophthalmic use Initial U.S. Approval: 199620251008
ba15fa83-c808-4298-bb0e-43ed1429c526brimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]34These highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 199620130315
a52b2033-0333-4630-9b1f-e22918b0962cbrimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]33These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution, 0.15% Initial U.S. Approval: 199620230404
e1ea003e-3dd9-41c7-9119-d1f209b9820bbrimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]31These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution, 0.15% Initial U.S. Approval: 199620230706
bc1785c5-1448-4791-9868-2fbbc8703b3bbrimonidine tartrate 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [SCD] · brimonidine tartrate 0.15 % Ophthalmic Drops [SY]3120100112